Answers are grounded in this paper and cite their sources.
High Resolution Image Download MS PowerPoint Slide Improvement of dietary protein content is of high interest for increasing the success of dietary intervention for management of metabolic diseases such as obesity/type-2 diabetes. The prevalence of metabolic diseases is increasing globally, and most patients progress to long-term pharmaceutical management. Blue whiting is an underutilized fish species with a high protein quality, representing a sustainable opportunity to improve upon current dietary intervention strategies. This study investigated the antidiabetic and appetite-suppressant potential of blue whiting protein hydrolysates (BWPHs) in an acute in vivo setting and in a chronic, diet-induced obese model. In acute studies in healthy mice, one BWPH (BW-SPH-A) elicited a 24.1% reduction in food intake ( p < 0.05) and another BWPH (BW-SPH-C) induced a significant improvement in blood glucose excursion ( p < 0.05). The effect of these two BWPH in a disease model was then assessed using C57Bl/6J mice fed a high-fat (45% kcal), high-sucrose (30% kcal) diet for 12 weeks. In this setting, neither BWPH appeared to significantly influence bodyweight or blood glucose. However, BW-SPH-C appeared to induce significant increases in average pancreatic islet area ( p < 0.001) and proliferation of beta-cells ( p < 0.01), along with a significant decrease in α-cell proliferation ( p < 0.001), which highlights the potential of this BWPH for the long-term management of T2DM. Further investigation of this BWPH in more severe models of T2DM is warranted.
No takes yet. Share an insight, caveat, or question.
Sharkey et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: